Loading...
Loss of Human Epidermal Growth Factor Receptor 2 (HER2) Expression in Metastatic Sites of HER2-Overexpressing Primary Breast Tumors
PURPOSE: We evaluated whether patients with human epidermal growth factor receptor 2 (HER2) –positive primary breast tumors had metastatic tumors that were HER2 positive (concordant) or HER2 negative (discordant). We then evaluated whether treatment with trastuzumab or chemotherapy before biopsy of...
Na minha lista:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society of Clinical Oncology
2012
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3295557/ https://ncbi.nlm.nih.gov/pubmed/22124109 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2010.33.8889 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|